Literature DB >> 7849328

Subcellular localization and quantitative analysis of Toxoplasma gondii target antigens of specific immunoglobulins G, M, A, and E.

E Kumolosasi1, A Bonhomme, A Beorchia, H Lepan, C Marx, F Foudrinier, M Pluot, J M Pinon.   

Abstract

The target antigens of specific immunoglobulins G, M, A, and E from patients with acquired acute toxoplasmosis were determined using immunocytochemistry. The relative repartition of these antigens in four cellular compartments of Toxoplasma (membrane complex, apical area, rhoptries, and dense granules) was quantitatively evaluated. Rhoptry antigens mainly react positively with IgA. Membrane, submembrane area (membrane complex), and rhoptry antigens are immunodominant for IgA and IgM. Apical area antigens are recognized by IgM two times more than IgG and IgA. IgE recognized only rhoptry antigens. The localization of pathogenetically antigenic components and their identification by the immune system appeared to be of importance for selection of immunodominant or recombinant antigens. Such localization would improve laboratory diagnosis of serious congenital toxoplasmosis or in immunocompromised patients with toxoplasmic complications after cyst reactivation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849328     DOI: 10.1002/jemt.1070290309

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  2 in total

1.  Kinetics study of the localization and quantitation of target antigens of immunoglobulin a antibodies in acquired and congenital toxoplasmosis.

Authors:  E Kumolosasi; A Bonhomme; A Beorchia; F Foudrinier; C Marx; M Pluot; J M Pinon
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

2.  Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.

Authors:  Yilin Wang; Lea Hedman; Visa Nurmi; Inga Ziemele; Maria F Perdomo; Maria Söderlund-Venermo; Klaus Hedman
Journal:  mSphere       Date:  2020-03-18       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.